MARKSANS — Marksans Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Marksans Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,094	3,467	7,151	7,003	7,085
Net Total Accounts Receivable
Net Total Receivables	2,714	3,978	4,195	4,591	5,523
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	9,023	12,012	16,753	18,625	22,041
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2,540	3,423	3,869	6,811	8,954
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	12,283	16,401	21,904	26,810	32,396
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,984	3,562	3,410	3,898	4,773
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	3,418	4,378	4,452	6,159	7,727
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	8,865	12,023	17,452	20,651	24,669
Total Liabilities & Shareholders' Equity	12,283	16,401	21,904	26,810	32,396
Total Common Shares Outstanding